Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity
- PMID: 14699049
- PMCID: PMC327176
- DOI: 10.1073/pnas.0307228101
Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity
Abstract
Defects in O-mannosylation of alpha-dystroglycan are thought to cause certain types of congenital muscular dystrophies with neuronal migration disorders. Among these muscular dystrophies, Walker-Warburg syndrome is caused by mutations in the gene encoding putative protein O-mannosyltransferase 1 (POMT1), which is homologous to yeast protein O-mannosyltransferases. However, there is no evidence that POMT1 has enzymatic activity. In this study, we first developed a method to detect protein O-mannosyltransferase activity in mammalian cells. Then, using this method, we showed that coexpression of both POMT1 and POMT2 (another gene homologous to yeast protein O-mannosyltransferases) was necessary for the enzyme activity, but expression of either POMT1 or POMT2 alone was insufficient. The requirement of an active enzyme complex of POMT1 and POMT2 suggests that the regulation of protein O-mannosylation is complex. Further, protein O-mannosylation appears to be required for normal structure and function of alpha-dystroglycan in muscle and brain. In view of the potential importance of this form of glycosylation for a number of developmental and neurobiological processes, the ability to assay mammalian protein O-mannosyltransferase activity should greatly facilitate progress in the identification and localization of O-mannosylated proteins and the elucidation of their functional roles.
Figures





Similar articles
-
POMT2, a key enzyme in Walker-Warburg syndrome: somatic sPOMT2, but not testis-specific tPOMT2, is crucial for mannosyltransferase activity in vivo.Glycobiology. 2008 Aug;18(8):615-25. doi: 10.1093/glycob/cwn042. Epub 2008 May 19. Glycobiology. 2008. PMID: 18490429
-
Mutations of the POMT1 gene found in patients with Walker-Warburg syndrome lead to a defect of protein O-mannosylation.Biochem Biophys Res Commun. 2004 Dec 3;325(1):75-9. doi: 10.1016/j.bbrc.2004.10.001. Biochem Biophys Res Commun. 2004. PMID: 15522202
-
Molecular cloning and characterization of rat Pomt1 and Pomt2.Glycobiology. 2006 Sep;16(9):863-73. doi: 10.1093/glycob/cwl002. Epub 2006 May 16. Glycobiology. 2006. PMID: 16704966
-
Expression and localization of fukutin, POMGnT1, and POMT1 in the central nervous system: consideration for functions of fukutin.Med Electron Microsc. 2004 Dec;37(4):200-7. doi: 10.1007/s00795-004-0260-5. Med Electron Microsc. 2004. PMID: 15614444 Review.
-
Glyc-O-genetics of Walker-Warburg syndrome.Clin Genet. 2005 Apr;67(4):281-9. doi: 10.1111/j.1399-0004.2004.00368.x. Clin Genet. 2005. PMID: 15733261 Review.
Cited by
-
Biochemical and biophysical changes underlie the mechanisms of basement membrane disruptions in a mouse model of dystroglycanopathy.Matrix Biol. 2013 Apr 24;32(3-4):196-207. doi: 10.1016/j.matbio.2013.02.002. Epub 2013 Feb 27. Matrix Biol. 2013. PMID: 23454088 Free PMC article.
-
Tight complex formation between Cosmc chaperone and its specific client non-native T-synthase leads to enzyme activity and client-driven dissociation.J Biol Chem. 2012 May 4;287(19):15317-29. doi: 10.1074/jbc.M111.312587. Epub 2012 Mar 13. J Biol Chem. 2012. PMID: 22416136 Free PMC article.
-
Old World and clade C New World arenaviruses mimic the molecular mechanism of receptor recognition used by alpha-dystroglycan's host-derived ligands.J Virol. 2007 Jun;81(11):5685-95. doi: 10.1128/JVI.02574-06. Epub 2007 Mar 14. J Virol. 2007. PMID: 17360738 Free PMC article.
-
Crystal structures of fukutin-related protein (FKRP), a ribitol-phosphate transferase related to muscular dystrophy.Nat Commun. 2020 Jan 16;11(1):303. doi: 10.1038/s41467-019-14220-z. Nat Commun. 2020. PMID: 31949166 Free PMC article.
-
Conditional knockout of protein O-mannosyltransferase 2 reveals tissue-specific roles of O-mannosyl glycosylation in brain development.J Comp Neurol. 2011 May 1;519(7):1320-37. doi: 10.1002/cne.22572. J Comp Neurol. 2011. PMID: 21452199 Free PMC article.
References
-
- Burton, E. A. & Davies, K. E. (2002) Cell 108, 5–8. - PubMed
-
- Emery, A. E. (2002) Lancet 359, 687–695. - PubMed
-
- Muntoni, F., Brockington, M., Blake, D. J., Torelli, S. & Brown, S. C. (2002) Lancet 360, 1419–1421. - PubMed
-
- Michele, D. E. & Campbell, K. P. (2003) J. Biol. Chem. 278, 15457–15460. - PubMed
-
- Holt, K. H., Crosbie, R. H., Venzke, D. P. & Campbell, K. P. (2000) FEBS Lett. 468, 79–83. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases